Towerview LLC Bristol Myers Squibb CO Transaction History

Towerview LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 30, 2020	SELL	$49.21 - $64.19 $246,050 - $320,950	-5,000 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$42.77 - $50.71 $855,400 - $1.01 Million	-20,000 Reduced 80.0%	5,000 $254,000
Q2 2019 Jul 25, 2019	BUY	$44.62 - $49.34 $669,300 - $740,100	15,000 Added 150.0%	25,000 $1.13 Million
Q1 2019 May 06, 2019	BUY	$45.12 - $53.8 $451,200 - $538,000	10,000 New	10,000 $477,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Towerview LLC, based on Form 13F filings with the SEC.

Stay updated on Towerview LLC with notifications on news.